Key facts
- It has raised $2.3M; the latest was Seed Round ($2.3M) in Dec 2025.
- Notable investors include Creative Destruction Lab, Vento, Wicklow Capital, AWS, Institute Of Science And Technology Austria — 10 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for Syntropic Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Syntropic Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Syntropic Medical
Operator of a medical device company intended to develop technologies that enhance the brain's neuroplasticity. The company focuses on advancing mental health care through the development of innovative technologies that target underlying causes of brain disorders, enabling people to access non-invasive and non-pharmaceutical treatment for mental health disorders.
- Sector
- Healthcare
- HQ
- Klosterneuburg, Austria
- Founded
- 2023
- Employees
- 10
- Website
- syntropicmedical.com/
- Ownership
- Privately Held (backing)
Syntropic Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Syntropic Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Syntropic Medical in its N-PORT filings yet. We sweep new filings monthly.